Diagnosed with malignant tumor at 22, this treatment has built a "defense line" for her again

Ms. Liu is still very young, and synovial sarcoma is highly malignant. Without other interventions, the tumor is highly likely to continue to progress. Ms. Liu is very worried about this. Through a friend's recommendation, Ms. Liu and her family learned about Professor Zhang Minghui's NKT technology from Tsinghua University School of Medicine, and carefully reviewed the demonstration cases of NKT cell therapy, particularly hoping to try it to reduce the risk of future metastasis and recurrence.

After reviewing Ms. Liu's medical records, Professor Zhang Minghui made the following analysis and judgment:

1. Synovial sarcoma generally occurs in younger patients and has a poorer prognosis, and Ms. Liu is also very young.  

2. The patient has completed neoadjuvant chemotherapy + surgery + postoperative chemotherapy, and the traditional treatment plan has been basically implemented.

3. After both surgery and chemotherapy are completed, the next step is to prevent recurrence and metastasis. NKT therapy utilizes powerful immune cells to eliminate tumor cells that may remain undetected in the body, with essentially no side effects. It is very friendly to patients and can reduce the occurrence of metastasis and recurrence.  

Ms. Liu received NKT cell immunotherapy in August 2020, and has completed 14 courses of treatment for a total of 16 months as of December 2021. During this period, multiple follow-up examinations showed no signs of significant tumor progression, and the overall assessment is stable!

Image aspect

Imaging examination: Reexamination of whole-body PET-CT in August 2021 showed no signs of recurrence or metastasis; Reexamination of lumbar MRI from October 2020 to February 2022 showed no space-occupying lesion on the right side of the psoas major muscle after surgery, with internal fixation devices visible in the lumbar vertebrae 1-5 and lumbar 3/4 level spinous processes, considered as postoperative changes.

Quality of Life

 

Ms. Liu's quality of life has been greatly improved. Her mental state is excellent, and she feels more energetic and vigorous than before, returning to her pre-illness state. She can lead a normal life and work without being affected by the disease.

Conclusion    Discussion

 

Ms. Liu achieved the expected results after adopting the NKT cell therapy method. After more than a year of treatment for synovial sarcoma, a highly malignant tumor, the latest assessment result remains stable with no progression observed.

Popular science knowledge is provided for reference only. For individual patients, clinical treatment should prevail.                    

Classic NKT case review

Click on the image

to view